Navigation Links
PAREXEL Expands Global Clinical Pharmacology Capabilities
Date:3/31/2008

historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "targets," and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the period ended December 31, 2007 as filed with the SEC on February 7, 2008, which "Risk Factors" discussion is incorporated by reference in this press release. The forward-looking st
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
2. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
3. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
4. Cellectar Expands Clinical Management Team
5. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
6. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
7. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
8. Gates Foundation Seeks Proposals for Innovative Global Health Research
9. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)...  Tokyo-based Atonarp Inc. announced today $8 million ... Walden Riverwood Ventures with participation from other co-investors.  ... Spectrometer technology platform, which will enable a broad ... oil & gas and healthcare industries for its ... partner with Atonarp in pursuing the commercialization of ...
(Date:8/19/2014)... 2014  AVIA – a provider-led accelerator that puts ... problems in healthcare ­– announces Sutter Health, a not-for-profit ... as the most recent addition to the AVIA Innovator ... AVIA,s inaugural cohort focused helping patients navigate the healthcare ... a patient,s providers so they work as a larger ...
(Date:8/19/2014)... , Aug. 19, 2014 According to ... component needed to make Big Data in healthcare a ... sales.  As part of the American Recovery and Reinvestment ... medical record (EMR) projects and penalties will start applying ... Kalorama Information, in its complete study of the EMR ...
Breaking Medicine Technology:Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2AVIA and Sutter Health Join Forces to Address Healthcare's Most Pressing Challenges 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
(Date:8/19/2014)... Horizon Blue Cross Blue Shield of New Jersey (Horizon ... teaming up during The Barclays at The Ridgewood County ... and Horizon BCBSNJ will be getting spectators into the walking ... own. , Horizon BCBSNJ, the official health care sponsor of ... to the New Jersey Golf Foundation, an organization that removes ...
(Date:8/19/2014)... News) -- Lupus and other rheumatic diseases can ... which can delay a correct diagnosis for months, ... diseases can also cause these types of symptoms, ... in Maywood, Ill. Rheumatic disorders include autoimmune ... tissues, such as lupus, systemic vasculitis and ankylosing ...
(Date:8/19/2014)... Grande Naturals, LLC is proud ... the 2014 Independent Cosmetics Manufacturers & Distributors Award ... position in “Product Innovation; Product Color Cosmetic” for ... includes a lash enhancement serum, GrandeLINER™. GrandeLINER™ ... , This all-new eyeliner is a ...
(Date:8/19/2014)... Merrick, NY (PRWEB) August 19, 2014 In honor ... helping you care for your old furry friend by offering tips ... to rely on their owners more. Because of this, dog owners ... for them. , As dogs age, their needs change. They will ... outside as much as they used to. Because of this, pet ...
(Date:8/19/2014)... (PRWEB) August 19, 2014 Following the completion ... Grand Hyatt Tampa Bay is proud to debut the ... second project included a full revamp of all public spaces ... guest rooms and suites, an all-new dining experience at 1823 ... hotel lobby. , With the introduction of 1823 Kitchen and ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 2Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 3Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 4Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 3Health News:The Puppy Store Helps Pet Owners Care for Aging Dogs 2Health News:Grand Hyatt Tampa Bay Hotel Unveils the Finishing Touches of Its $20 Million Makeover 2
... park is more than just a nice way to ... health, according to University of Illinois environment and behavior ... advocates, landscape architects, and popular writers have consistently claimed ... recently, their claims haven,t undergone rigorous scientific assessment." ...
... California, San Diego School of Medicine say antibodies to ... be useful as a future biomarker for predicting cancer ... concentration, used as a treatment for suppressing tumor growth. ... MD, assistant clinical professor of medicine, and Ajit Varki, ...
... News) -- Motorcycle deaths in the United States fell by about ... row fatalities have declined, according to a new report. The ... accidents in 2010 than in 2009, according to a report released ... estimated 4,465 were killed in 2009 compared to 4,376 in 2010. ...
... prohibition against testosterone therapy in men with untreated or ... study published in The Journal of Urology . ... a history of prostate cancer, even if treated and ... to the belief that testosterone activated prostate cancer growth, ...
... Translational Behavioral Medicine: Practice, Policy, Research (TBM), ... The journal will debut with a special section, ... Behavioral Medicine is an international, peer-reviewed journal ... is to engage, inform, and catalyze dialogue among ...
... study published in The American Journal on Addictions ... have high rates of substance use disorders. , Led by ... used national administrative data from the Department of Veterans Affairs ... served in Iraq and Afghanistan who were also diagnosed with ...
Cached Medicine News:Health News:Green environments essential for human health 2Health News:Green environments essential for human health 3Health News:Green environments essential for human health 4Health News:A cancer marker and treatment in 1? 2Health News:A cancer marker and treatment in 1? 3Health News:Motorcycle Deaths Drop for Second Straight Year: Report 2Health News:Study suggests another look at testosterone-prostate cancer link 2Health News:Study suggests another look at testosterone-prostate cancer link 3Health News:Springer launches new journal, Translational Behavioral Medicine: Practice, Policy, Research 2
... Radianse indoor positioning supports patient ... length-of-stay. Ensure the right patients are ... right procedures. Respond to the exact ... or a monitor alarms. Measure patient ...
MONOJECT MAGELLAN Safety Blood Collection Needle...
... Eclipse Blood Collection Needle consists of a ... a safety shield aligned to the bevel-up ... Vacutainer Eclipse Blood Collection Needle has its ... to attach a secondary safety accessory. Immediate, ...
... Shielding Blood Collection Needle is designed ... protection against needlesticks during a blood ... automatically upon insertion of the first ... the first tube is inserted through ...
Medicine Products: